AIMCA
ASBPW

Alberta Investment Management Corp (AIMCo)’s Aspire Biopharma Warrant ASBPW Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio ASBPW Stock Details ASBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-250,000
Closed -$16.9K – 942
2025
Q1 		$16.9K Buy
+250,000
New +$15.1K ﹤0.01% 741

Other funds holding ASBPW

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s ASBPW Position: Q2 2025 in Review

Alberta Investment Management Corp (AIMCo) sold out of Aspire Biopharma Warrant (ASBPW) in Q2 2025, closing a stake of 250,000 shares — an estimated $16.9K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in ASBPW in Q1 2025 and held it in 1 quarter. The position peaked at $16.9K in Q1 2025. 29 funds tracked by Wall St. Rank hold ASBPW as of Q2 2025.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Aspire Biopharma Warrant position as of Q2 2025 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 250,000 Aspire Biopharma Warrant shares in Q2 2025, an estimated $16.9K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Aspire Biopharma Warrant in Q1 2025 and held it in 1 quarter.
  • Alberta Investment Management Corp (AIMCo)'s Aspire Biopharma Warrant position peaked at $16.9K in Q1 2025.
  • 29 funds tracked by Wall St. Rank held Aspire Biopharma Warrant as of Q2 2025.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2025, filed 8 Aug 2025.